AZTREONAM THERAPY FOR SERIOUS GRAM-NEGATIVE INFECTIONS IN CHILDREN

被引:19
|
作者
STUTMAN, HR
CHARTRAND, SA
TOLENTINO, T
FRIEDHOFF, L
MARKS, MI
机构
[1] UNIV OKLAHOMA,HLTH SCI CTR,DEPT PEDIAT,OKLAHOMA CITY,OK 73190
[2] UNIV S ALABAMA,DEPT PEDIAT,MOBILE,AL 36688
[3] MERCY HLTH CTR,DEPT NEONATAL MED,OKLAHOMA CITY,OK
[4] SQUIBB INST MED RES,PRINCETON,NJ 08540
来源
关键词
D O I
10.1001/archpedi.1986.02140250073038
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:1147 / 1151
页数:5
相关论文
共 50 条
  • [21] CEFTAZIDIME IN THE THERAPY OF SERIOUS GRAM-NEGATIVE BACILLARY INFECTIONS
    POTTAGE, JC
    KARAKUSIS, PH
    FLIEGELMAN, RM
    LEVIN, S
    TRENHOLME, GM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 223 - 228
  • [22] PHARMACOKINETICS OF AZTREONAM IN PATIENTS WITH GRAM-NEGATIVE INFECTIONS
    JANICKE, DM
    CAFARELL, RF
    PARKER, SW
    APICELLA, MA
    JUSKO, WJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (01) : 16 - 20
  • [23] SAFETY AND EFFICACY OF AZTREONAM (AZT) THERAPY OF GRAM-NEGATIVE INFECTIONS OF CHILDHOOD
    SWENSON, E
    GOOCH, WM
    HIGBEE, MD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 220 - 220
  • [24] USE OF AZTREONAM (SQ26,776) IN THE MANAGEMENT OF SERIOUS GRAM-NEGATIVE INFECTIONS
    CONE, LA
    WOODARD, DR
    BYRD, RG
    STOLTZMAN, DW
    CLINICAL RESEARCH, 1984, 32 (01): : A42 - A42
  • [25] Treatments for serious Gram-negative infections
    Rello, J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S58 - S59
  • [26] MECILLINAM IN SERIOUS GRAM-NEGATIVE INFECTIONS
    ROSENBERGER, R
    KING, JW
    CLINICAL RESEARCH, 1981, 29 (02): : A395 - A395
  • [27] CEFOTAXIME THERAPY OF SERIOUS INFECTIONS WITH MULTIRESISTANT GRAM-NEGATIVE BACILLI
    CLUMECK, N
    VANLAETHEM, Y
    VANHOOF, R
    GEORGE, C
    RAPIN, M
    BUTZLER, JP
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1982, 14 (01) : 57 - 60
  • [28] The role of carbapenems in initial therapy for serious Gram-negative infections
    Rahal, James J.
    CRITICAL CARE, 2008, 12
  • [29] The role of carbapenems in initial therapy for serious Gram-negative infections
    James J Rahal
    Critical Care, 12 (Suppl 4):
  • [30] CEFOTAXIME THERAPY OF SERIOUS MULTIRESISTANT GRAM-NEGATIVE BACILLARY INFECTIONS
    VANLAETHEM, Y
    CLUMECK, N
    VANHOOF, R
    GEORGE, C
    RAPIN, M
    BUTZLER, JP
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1981, 7 (04) : 405 - 406